A case series evaluating patient perceptions after switching from nusinersen to risdiplam for spinal muscular atrophy.
Jeffrey C PowellJames B MeilingMichael S CartwrightPublished in: Muscle & nerve (2023)
These results suggest that most patients are satisfied when switching from nusinersen to risdiplam, with the method of delivery being a primary factor.